Th1 Platform Immune Responses Against Leishmania major Induced by Thiol-Specific Antioxidant-Based DNA Vaccines
about
Possibilities and challenges for developing a successful vaccine for leishmaniasisComparative Assessment of Induced Immune Responses Following Intramuscular Immunization with Fusion and Cocktail of LeIF, LACK and TSA Genes Against Cutaneous Leishmaniasis in BALB/c Mice.Immunogenicity and efficacy of a bivalent DNA vaccine containing LeIF and TSA genes against murine cutaneous leishmaniasis.Alternative to Chemotherapy-The Unmet Demand against Leishmaniasis.
P2860
Th1 Platform Immune Responses Against Leishmania major Induced by Thiol-Specific Antioxidant-Based DNA Vaccines
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Th1 Platform Immune Responses ...... Antioxidant-Based DNA Vaccines
@ast
Th1 Platform Immune Responses ...... Antioxidant-Based DNA Vaccines
@en
Th1 Platform Immune Responses ...... Antioxidant-Based DNA Vaccines
@nl
type
label
Th1 Platform Immune Responses ...... Antioxidant-Based DNA Vaccines
@ast
Th1 Platform Immune Responses ...... Antioxidant-Based DNA Vaccines
@en
Th1 Platform Immune Responses ...... Antioxidant-Based DNA Vaccines
@nl
prefLabel
Th1 Platform Immune Responses ...... Antioxidant-Based DNA Vaccines
@ast
Th1 Platform Immune Responses ...... Antioxidant-Based DNA Vaccines
@en
Th1 Platform Immune Responses ...... Antioxidant-Based DNA Vaccines
@nl
P2860
P50
P356
P1476
Th1 Platform Immune Responses ...... Antioxidant-Based DNA Vaccines
@en
P2093
Abdolhossein Dalimi
Fatemeh Ghaffarifar
P2860
P356
10.5812/JJM.8974
P577
2014-02-01T00:00:00Z